The company's packing in the latest technology at its APICOM facility in Dublin. A key feature is more effective and timely use of process data.
- Is The BIOSECURE Act The First Real Step Toward Reshoring?
- Defining When To Implement Technologies To Support Commercial Growth
- Sourcing Plasmid DNA From CDMOs Got More Challenging — Here's Why
- Considerations For Potency Assurance Of CGT Products
- 3 Focus Areas To Transition From Clinical To Commercial Readiness
- How Recce Is Delivering 5,000 Doses Per Week For Its Clinical Trials
- Cell & Gene Therapies: Avoid This Common Pitfall In Supply Chain Planning
- Exploring Sanofi R&D's Batch Monitoring Initiative
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Industry Trends: Clinical Logistics Outsourcing
Understanding industry trends, market dynamics, and the selection criteria decision-makers apply when choosing a clinical logistics service provider informs and contextualizes outsourcing decisions.
-
Optimizing Direct-To-Patient Supply Management: ClinChoice And 89Bio
Learn how the CRO ClinChoice and the sponsor 89Bio were conducting a phase II, randomized, double-blind, placebo-controlled study that needed to pivot to a decentralized protocol during the pandemic or face trial disruption.
-
The Changing Dynamics Of The Pharma/Biotech Supply Chain – A Packaging And Clinical Supply Perspective
Perhaps more than any other industry, pharma and biotech have undergone radical change over the past year, as a result of the COVID-19 pandemic. From supply chain security and capacity to clinical trial operations and site auditing, almost every aspect has been affected. Experts explore how these trends are shaping the industry and offer an outlook.
-
Enhancing Clinical Supply Chain With Signant SmartSignals Supplies
A global pharma leader improved supply chain efficiency and compliance by digitalizing processes with Signant's SmartSignals Supplies, achieving better visibility, traceability, and reduced errors.
-
5 Common Clinical Supply Chain Speedbumps
Clinical trials can be very complex. Discover the need to connect planning and oversight from sourcing to shipping, along with mastering requirements such as cold chain, border slowdowns, and data privacy.
-
How Clinical Trial Complexity Impacts End Users
This article examines clinical trial complexity through the lens of study investigators, site staff, CRAs, sponsor study and supply managers, and how the RTSM/ IRT provides the ability to be as creative as needed.
-
Addressing Rare Disease Drug Product Manufacturing Challenges
Handling development and manufacturing challenges for orphan drugs requires experience, expertise and scalable technologies, along with a flexible and agile supply chain.
-
What To Look For In Your IRT/RTSM Solution For A Simpler Trial Execution
Which factors should you consider when selecting an IRT/RTSM vendor to ensure your trial's randomization and supply management processes are successfully executed?
-
The Tale Of Two Clinical Supply Chains: The Risks Of Fragmented Systems
This article examines two contrasting approaches to showcase how a centralized inventory management system is an effective tool for supporting a robust supply chain.
-
Revolutionizing Trial Supply Management With The Power of Free Picking
Discover the power of SmartSignals RTSM’s new free picking feature, designed to revolutionize trial supply management by optimizing efficiency and reducing costs.
CATALENT CORNER
Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.